6738-23-4

Basic information

• Product Name: 2,4-DIMETHYLANISOLE
• Synonyms: 2,4-Dimethylanisol;2 4-DIMETHYLANISOLE 97+%;2,4-Dimethylanisole,99%;4-METHOXY-M-XYLENE;1,3-DIMETHYL-4-METHOXYBENZENE;2,4-DIMETHYLANISOLE;FEMA 3828;1-Methoxy-2,4-dimethylbenzene
• CAS NO: 6738-23-4
• Molecular Formula: C₉H₁₂O
• Molecular Weight: 136.19
• EINECS: 229-794-9
• Product Categories: Anisoles, Alkyloxy Compounds & Phenylacetates;Alphabetical Listings;C-D;Flavors and Fragrances;Ethers;Organic Building Blocks;Oxygen Compounds;Building Blocks;C9;Chemical Synthesis;Organic Building Blocks;Oxygen Compounds
• Mol File: 6738-23-4.mol

Chemical Properties

• Boiling Point: 191 °C(lit.)
• Flash Point: 146 °F
• Appearance: Clear colorless/Liquid
• Density: 0.973 g/mL at 25 °C(lit.)
• Refractive Index: n20/D 1.514(lit.)
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 2,4-DIMETHYLANISOLE(CAS DataBase Reference)
• NIST Chemistry Reference: 2,4-DIMETHYLANISOLE(6738-23-4)
• EPA Substance Registry System: 2,4-DIMETHYLANISOLE(6738-23-4)

Safety Data

• Hazard Codes: Xn
• Statements: 36/37/38-41-37/38-22
• Safety Statements: 24/25-26
• RIDADR: 3271
• WGK Germany: 3
• Hazardous Substances Data: 6738-23-4(Hazardous Substances Data)

Usage

Uses

Used in Flavor and Fragrance Industry:
2,4-Dimethylanisole is used as a flavoring agent for its distinctive aroma, adding a spicy and herbaceous note to various food products.
Used in Aromatherapy:
2,4-Dimethylanisole is used as an essential oil in aromatherapy for its potential relaxing and mood-enhancing properties.
Used in Perfumery:
2,4-Dimethylanisole is used as a fragrance ingredient in the creation of perfumes and colognes, contributing to its unique and appealing scent profile.

Synthesis Reference(s)

The Journal of Organic Chemistry, 43, p. 4672, 1978 DOI: 10.1021/jo00418a036

InChI:InChI=1/C9H12O/c1-7-4-5-9(10-3)8(2)6-7/h4-6H,1-3H3

Upstream product

• 824-94-2 p-methoxybenzyl chloride 
• 75-57-0 tetramethlyammonium chloride 
• 105-67-9 2,4-Xylenol 
• 94002-16-1 2,4-dimethylphenyl 4-methylbenzenesulfonate 
• 865-33-8 potassium methanolate 
• 67-56-1 methanol 
• 72900-28-8 2-((Z)-4-(tetrahydro-2H-pyran-2-yloxy)but-2-enyloxy)-tetrahydro-2H-pyran 
• 114787-91-6 (4-methoxy-3-methylphenyl)methanol 
• 578-58-5 2-methylmethoxybenzene 
• 104-93-8 p-methylanizole 
• 64-17-5 ethanol 
• 7048-41-1 2-methoxy-5-methylbenzyl chloride 
• 108-95-2 phenol 
• 38474-03-2 1-(isopropylthio)-3-methoxybenzene 

Downstream Products

• 78334-92-6 3-(5-methoxy-2,4-dimethylbenzoyl)propionic acid 
• 61626-96-8 2-chloro-N-<(2-methoxy-3,5-dimethylphenyl)methyl>acetamide 
• 83020-58-0 2,4-bis(bromomethyl)-1-methoxybenzene 
• 16762-34-8 (2-hydroxy-3,5-dimethylphenyl)(phenyl)methanone 
• 103323-25-7 1-(5-hydroxy-2,4-dimethyl-phenyl)-ethanone 
• 77329-25-0 5-ethyl-2,4-dimethyl-anisole 
• 70347-04-5 4-Methoxy-3-methylbenzoesaeure-methylester 
• 4074-46-8 2-propyl-4-methylphenol 
• 124267-95-4 4-Methyl-2-sec-butylphenetole 
• 124267-96-5 4-Methyl-2-propylphenetole 
• 124267-97-6 2,4-Dipropylphenetole 
• 99430-04-3 2'-hydroxy-3',5'-dimethylchalcone 
• 55169-98-7 2’-methoxy-3’,5’-dimethylacetophenone 
• 2206-43-1 4-methoxyisophthalic acid 

Relevant articles and documents

Preparation method of nitrogen-alkyl (deuterated alkyl) aromatic heterocycle and alkyl (deuterated alkyl) aryl ether compound

The invention provides a method for preparing nitrogen-alkyl(deuterated alkyl)aromatic heterocycle and alkyl(deuterated alkyl)aryl ether compounds. The method adopted in the invention specifically comprises the following steps: firstly, adding an alkoxy base (MOR') or a combination reagent Q (comprising a base M'X, an alcohol C and a molecular sieve E) into a solvent B to be stirred; then, addingan aromatic compound D of nitrogen sulfonyl or oxygen sulfonyl into a mixture; separating and purifying after reaction to obtain nitrogen-alkyl(deuterated alkyl)aromatic heterocycle or alkyl(deuterated alkyl)aryl ether. The method can realize one-step conversion from an electron withdrawing benzenesulfonyl protecting group on a nitrogen or oxygen atom to an electron donating alkyl protecting group, avoids using highly toxic alkyl halide, and has advantages of being efficient, economical, environmentally friendly, mild in condition, good in substrate universality and high in yield; the prepareddeuterated compounds can be widely applied to the fields of pharmaceutical chemistry and organic chemistry synthesis.

Electro-Oxidative Selective Esterification of Methylarenes and Benzaldehydes

A mild and green electro-oxidative protocol to construct aromatic esters from methylarenes and alcohols is herein reported. Importantly, the reaction is free of metals, chemical oxidants, bases, acids, and operates at room temperature. Moreover, the design of the electrolyte was found critical for the oxidation state and structure of the coupling products, a rarely documented effect. This electro-oxidative coupling process also displays exceptional tolerance of many fragile easily oxidized functional groups such as hydroxy, aldehyde, olefin, alkyne, as well as neighboring benzylic positions. The enantiomeric enrichment of some chiral alcohols is moreover preserved during this electro-oxidative coupling reaction, making it overall a promising synthetic tool.

[OONN] tetradentate fourth subgroup metal complexes as well as preparation method and application thereof

The invention relates to the technical field of olefin polymerization catalysts, and particularly discloses [OONN] tetradentate fourth subgroup metal complexes, a preparation method and application. The [OONN] tetradentate fourth subgroup metal complexes have a structure which is shown in the specification. The [OONN] tetradentate fourth subgroup metal complexes provided by the invention can catalyze ethylene polymerization and ethylene and alpha-olefin copolymerization, and in the polymerization process, the heat resistance is good, and the polymerization time is long. The complexes are simple in synthesis method, easy to prepare and high in yield, the structure is convenient to modify, the complexes can be used for catalyzing ethylene polymerization and ethylene and alpha-olefin copolymerization after being activated by a proper cocatalyst, the problems that an existing olefin polymerization catalyst is relatively tedious in preparation process, high in cost and low in catalytic activity are solved, and the complexes have good industrial application value and wide application field.

Synthesis and in vitro activities on anti-platelet aggregation of 4-methoxy-1,3-phthalamidesamides and benzenedisulfonamides

Cardiovascular diseases are the most frequent cause of morbidity and mortality worldwide. In order to discover novel compounds with anti-platelet aggregation activities, a series of novel 4-methoxy-1,3-phthalamidesamides (1a–1i) and a series of novel 4-methoxy-1,3-benzenedisulfon-amides (2a–2i) were synthesized and their anti-platelet aggregation activities were evaluated by the turbidimetric method in response to the following agonists: adenosine diphosphate (ADP), arachidonic acid (AA), and Collagen. Those compounds that have better in vitro activities were subjected to cell toxicity tests via cell counting kit-8 (CCK-8) assay. The inhibition rates of anti-platelet in vitro of five compounds 1g (39.45%), 2d (38.87%), 2g (38.55%), 2h (44.56%), and 2i (43.93%) were higher than that of two reference drugs picotamide (36.12%) and aspirin (38.45%) when ADP was selected as an inducer. The inhibition rates of seven compounds 1c (43.63%), 1d (40.02%), 1g (47.42%), 1i (40.45%), 2c (40.11%), 2d (40.45%), and 2i (49.05%) were higher than that of picotamide (34.89%) and aspirin (39.43%) when AA was selected as inducer. And the inhibition rates of five compounds 1d (47.22%), 1i (45.01%), 2d (38.74%), 2e (42.21%), and 2f (39.94%) were higher than picotamide (38.45%) and aspirin (37.08%) when collagen was selected as inducer. Moreover, the effect of cell toxicity exhibited that none of the compounds had obvious cell toxicity against L-929 cells. Therefore, 4-methoxy-1,3-phthalamidesamides (1a–1i) and 4-methoxy-1,3-benzenedisulfon-amides (2a–2i) have the potential to become a novel kind of anti-platelet drugs and deserve further study.

Detosylative (Deutero)alkylation of Indoles and Phenols with (Deutero)alkoxides

An efficient strategy for N/O-(deutero)alkylation of indoles and phenols with alkoxides/alcohols as the alkylation reagents is described. The consecutive detosylation/alkylation transformations feature mild reaction conditions, high ipso-selectivity, and good functional group tolerance (>50 examples). A one-pot selective N-alkylation of unprotected indoles with alcohols and TsCl is also realized. The application of this method is demonstrated by the introduction of isotope-labeled (CD3 and 13CH3) groups using the readily accessible labeled alcohols and the synthesis of pharmaceuticals.

4,5-Dimethyl-2-Iodoxybenzenesulfonic Acid Catalyzed Site-Selective Oxidation of 2-Substituted Phenols to 1,2-Quinols

A site-selective hydroxylative dearomatization of 2-substituted phenols to either 1,2-benzoquinols or their cyclodimers, catalyzed by 4,5-dimethyl-2-iodoxybenzenesulfonic acid with Oxone, has been developed. Natural products such as biscarvacrol and lacinilene C methyl ether could be synthesized efficiently under mild reaction conditions. Furthermore, both the reaction rate and site selectivity could be further improved by the introduction of a trialkylsilylmethyl substituent at the 2-position of phenols. The corresponding 1,2-quinols could be transformed into various useful structural motifs by [4+2] cycloaddition cascade reactions.

DEUTERATED BENZOPYRAN COMPOUND AND APPLICATION THEREOF

features as shown in Formula (I), or pharmaceutically acceptable salts or stereoisomers thereof, or prodrug molecules thereof. With excellent anti-inflammatory and analgesic effects and the capability to inhibit growth of tumor cells, such compounds are novel COX-2 selective inhibitors. The compounds and pharmaceutically acceptable salts thereof disclosed by the present application can be applied in preparing anti-inflammatory and analgesic drugs and drugs for treating or preventing tumors.

Deuterated Benzopyran Compounds and Application Thereof

The present invention discloses deuterated benzopyran compounds having structure features as shown in Formula (I), or pharmaceutically acceptable salts or stereoisomers thereof, or prodrug molecules thereof. With excellent anti-inflammatory and analgesic effects and the capability to inhibit growth of tumor cells, such compounds are novel COX-2 selective inhibitors. The compounds and pharmaceutically acceptable salts thereof disclosed by the present application can be applied in preparing anti-inflammatory and analgesic drugs and drugs for treating or preventing tumors.

Improved Protocol for Mononitration of Phenols with Bismuth(III) and Iron(III) Nitrates

A simple and efficient multigram procedure was developed for the selective mononitration of various activated phenols. The reaction proceeded smoothly with 0.5 equivalents of Bi(NO3)3 · 5H2O or Fe(NO3)3 · 9H2O in acetone at ambient temperature or at reflux. The desired products were isolated in 62-93% total yield and essentially no overnitrated compounds were detected.

NEW PROCESSES FOR PREPARING 4-SUBSTITUTED IMIDAZOLES

There is provided a novel process for the preparation of a compound of formula (I), (Formula (I)). There is also provided novel processes to intermediates of the compound of formula (I), as well as novel intermediates themselves.